A large body of evidence has convincingly shown that Toll-like receptors are necessary sensors for infections with pathogens, but their activation was also suggested to generate autoimmunity. During experimental infections, the lack of these sensors or of their signaling molecules should lead to a deficient immune response. We found out that MyD88, the major adaptor of the Toll/interleukin-1 (Toll/IL-1) receptor signaling pathway, can actually act as a negative regulator of B-cell function in some settings. MyD88-deficient mice infected by Borrelia burgdorferi developed extreme hypergammaglobulinemia compared to wild-type animals, with high levels of immunoglobulin M (IgM) autoantibodies. In vivo, cell transfer experiments and cell blocking assays showed that this phenotype was not linked to the absence of MyD88 in B cells but rather to CD4 T-cell and likely dendritic cell dysfunctions leading to a Th1-to-Th2 cytokine switch. In addition, our results suggest a relative defect in the Ig class switch recombination process, since MyD88 knockout mice developed mostly IgM antibodies. Collectively, these data emphasize the complex role of the Toll/IL-1 receptor pathway in tuning the immune response against infection and avoiding autoimmunity.
Polyclonal lymphocyte activation is a general consequence of bacterial, viral, and parasitic infections. Generally speaking, three main consequences associated with polyclonal lymphocyte activation, i.e., protection from infection, immunosuppression, and autoimmunity, have been described, depending on the nature of the infectious agent. On the one hand, this nonspecific lymphocyte activation, largely exceeding the level of the specific antipathogen response, could control pathogen dissemination (33) . On the other hand, it is able to inhibit the host-specific response to lymphocytic choriomeningitis virus, impairing virus neutralization (35) , or to negatively influence the course of murine Trypanosoma cruzi infection (28) . Finally, in humans, hypergammaglobulinemia and significant levels of autoantibodies, including rheumatoid factors (RFs) and antinuclear antibodies, are frequently described during the active phases of infectious states, sometimes leading to tissue damage. Experimentally, the mechanisms which govern pathogeninduced polyclonal B-cell activation seem diverse and include direct mitogenic properties of the experimental pathogens (possibly via membrane-bound Toll-like receptors [TLRs] , but also via nonvariable regions of the membrane-bound immunoglobulin [Ig]) (2, 10, 36) as well as cognate CD4 T-cell help induced by B-cell-presented pathogen-derived peptides (14) . Where analyzed, autoantibodies were frequently produced during the course of these experimental infections.
These general considerations could have important implications regarding the occurrence of autoimmune diseases. Indeed, in a scenario of a multistep process leading to overt autoimmunity, infection-induced polyclonal lymphocyte activation is regularly considered an early candidate event that can drive autoreactive B lymphocytes into an affinity maturation pathogenic process (41) . If this scenario is correct, uncontrolled nonspecific B-cell activation during infection could be harmful. However, to date, very little is known about the mechanisms which control nonspecific B-cell activation during infection.
In order to understand the mechanisms of the autoreactive B-cell tolerance breakdown during experimental bacterial infection with Borrelia burgdorferi, we previously designed experimental infections of self-reactive B-cell transgenic mice (42) . We showed in vitro that TLRs expressed on B cells were implicated not only in autoantibody production but also in nonspecific B-cell activation (42) . We expected that, in vivo, TLR-deficient mice would have been devoid of such a nonspecific B-cell activation. However, to our surprise, mice deficient in the major adaptor protein of the Toll/interleukin-1 (Toll/ IL-1) receptor signaling pathway, MyD88, were found to exhibit dramatic nonspecific B-cell activation, hypergammaglobulinemia, and high levels of autoantibodies during the course of B. burgdorferi infection. Thus, MyD88 appears to control potentially harmful nonspecific B-cell activation.
were performed with the approval of the Direction Départementale des Services Vétérinaires (Strasbourg, France).
B. burgdorferi infection. The B. burgdorferi sensu stricto cN40 isolate was cultivated at low passage in Barbour-Stoenner-Kelly (BSK-H) medium (Sigma) supplemented with 6% normal rabbit serum (Sigma) at 33°C. Four-to 5-weekold mice were infected with 10 6 spirochetes by needle injection of 0.1 ml in the shaved back skin. Control mice were injected with an equal volume of sterile BSK-H medium and housed under the same conditions as infected animals. Mice were sacrificed 3 to 4 weeks after inoculation. In one experiment, mice of 8 to 10 weeks of age were used, with results similar to those for mice of 4 to 5 weeks of age (B-and T-cell statuses of MyD88 KO versus MyD88 ϩ/Ϫ mice, both infected and noninfected animals, with three mice in each group). The infectious status of the animals was evaluated by culture of different specimens (bladder, ear, heart, and spleen) in 7-ml tubes of BSK-H medium for up to 4 weeks at 33°C.
Quantitative PCR. DNAs were extracted from the joints and lymph nodes (LN) of individual mice on a MagNA Pure system (Roche Diagnostics, France), using a MagNA Pure LC large-volume DNA isolation kit after external lysis by collagenase A and then proteinase K.
Quantification of the B. burgdorferi-specific fla gene was done on a LightCycler system (Roche Diagnostics, France). The primers used to amplify the fla gene were those previously described (16) . Quantification of the mouse-specific gapdh gene was done on an ABI Prism 7000 instrument (Applera, Courtaboeuf, France), using a commercial kit (TaqMan rodent GADPH control reagent; Applera). External standards for fla and gapdh genes were developed as previously described (49) . The number of B. burgdorferi cells in tissue specimens was calculated by comparing the crossing points of the samples with those of the standards and was normalized to 10 4 gapdh DNA copies.
Flow cytometry. Preparation of LN and spleen cell suspensions, their staining for flow cytometry, and analysis of the B-cell phenotype have been described already (20, 42) . T cells were monitored using double staining with anti-CD3fluorescein isothiocyanate (anti-CD3-FITC), anti-CD4-phycoerythrin (anti-CD4-PE), or anti-CD8-FITC (Pharmingen) or triple staining with anti-CD4-PE, anti-CD25-biotin, and anti-CD45RB-FITC antibodies (Pharmingen) for regulatory T cells. Dendritic cells (DCs) were identified by anti-CD11c-biotin (Pharmingen) staining. Expression analysis of the activation marker CD86 was performed using anti-CD86-PE antibody (Pharmingen). Nonviable cells were excluded and identified by incorporation of propidium iodide (PI; 5 mg/ml). The analysis was performed with a FACSCalibur flow cytometer, using the CellQuest software package (BD Biosciences).
ELISA. Mice were bled by retro-orbital puncture under anesthesia. Sera were centrifuged (12 min, 10,000 rpm) and stored at Ϫ20°C until enzyme-linked immunosorbent assay (ELISA) analysis.
ELISAs for serum IgM were done as described previously (10, 46) . For murine RF, plates were coated with total murine IgG (50 mg/ml; Jackson ImmunoResearch), and serum RF concentrations were revealed by adding a peroxidase-coupled anti-mouse IgM. For anti-double-stranded-DNA (anti-dsDNA) antibodies, calf thymus DNA was absorbed at 10 g/liter (Sigma); single-stranded DNA was removed by digestion with S1 nuclease (100 IU/ml; Amersham), and bound antibodies were revealed with anti-mouse IgM-peroxidase (80 ng/ml; Jackson ImmunoResearch). For anti-thyroglobulin antibodies, plates were coated with thyroglobulin (50 g/ml; Sigma), and binding of antibodies was revealed by adding anti-mouse IgM-peroxidase (80 ng/ml; Jackson ImmunoResearch). In each test (RF, anti-dsDNA, and anti-tyrosine), sera from MRL/lpr mice were used as positive controls; sera of MRL/lpr, MyD88 ϩ/Ϫ , and MyD88 KO mice were tested using 1/100, 1/250, 1/500, and 1/1,000 dilutions.
Mouse sera were tested for murine IgG antibodies to B. burgdorferi as previously described (42.) Anti-mouse IgG1, IgG2b, and IgG3 (Jackson Immuno-Research) were used to reveal the different Ig isotypes (1/2,000 dilution).
For murine IgE, plates were coated with anti-murine IgE antibody (1 g/ml; Pharmingen), and then a biotin-coupled anti-mouse IgE (0.5 g/ml; Pharmingen) was added and serum concentrations of IgE were revealed using peroxidasecoupled streptavidin (1/20,000; Jackson ImmunoResearch).
ELISAs for IL-12, gamma interferon (IFN-␥), IL-4, and IL-10 were done using commercial kits (Bender Medsystems) as described by the manufacturer, using diluted sera (1/5 and 1/10 dilutions) and culture supernatants.
Cell purification. Spleen or draining LN were harvested from 8-to 12-weekold mice.
Cells were isolated with a magnetic cell separation (MACS) depletion protocol (Miltenyi Biotec). Single-cell suspensions were depleted of non-B cells with anti-CD43 magnetic beads (Miltenyi Biotec). The purity of B cells was confirmed by staining with anti-CD19 antibody (Ͼ90% purity) and with anti-B220 antibody (Ͼ98% purity). T cells were purified using a pan-T-cell isolation kit (anti-CD11b, anti-CD45R, anti-DX5, and anti-Ter119 negative sorting; Miltenyi Biotec). In all experiments, Ͼ95% of recovered cells were CD3 positive.
B-cell proliferation assays. Spleens or LN were removed from MyD88 KO mice, MyD88 ϩ/Ϫ mice, or control C57BL/6 mice and teased apart. The proliferation assays were done as previously described (42) . Cells (10 6 ) were incubated in 24-well BD Falcon plates (final volume of 1 ml) with one of the following reagents: 10 g/ml of lipopolysaccharide (LPS) from Salmonella enterica serovar Typhosa (Sigma), 10 g/ml of an F(abЈ) 2 goat anti-mouse IgM (Jackson Immu-noResearch), or 10 g/ml of sonicated B. burgdorferi. After 60 h of culture at 37°C, the phenotype of the cells was determined by flow cytometry analysis.
Preparation of sonicated B. burgdorferi. Sonicated B. burgdorferi organisms were prepared as previously described (42) . The protein content of the preparation was determined by Lowry assay.
B-cell-depleted LN cell culture. LN cells from infected MyD88 KO or MyD88 ϩ/Ϫ mice were depleted of B cells (20 days after infection) by use of anti-CD19 magnetic beads (Miltenyi Biotec). In each well, 7 ϫ 10 5 MyD88 KO or MyD88 ϩ/Ϫ B-cell-depleted LN cells were cultured in the presence of 10 g/ml sonicated B. burgdorferi cells. Unstimulated cultures were used as controls.
B-and T-cell transfer. MT mice were given 5 ϫ 10 7 MACS-purified B cells by intravenous transfer 3 days before B. burgdorferi infection. CD3ε KO mice received the transfer in the same way, but with 2 ϫ 10 7 MACS-purified T cells.
Anti-CD4 treatment (8, 21, 42, 46) . Nondepleting mouse anti-CD4 antibody (YTS177.9.6.1), in ascites form and diluted in phosphate-buffered saline (PBS) (50 l ascites plus 50 l PBS per mouse per injection), was administered intraperitoneally 2 days before B. burgdorferi infection and then twice a week until sacrifice. Control animals were injected with PBS. CD4-T-cell blockade was visualized with an LN CD4-CD8 stain as previously described (46) .
DC differentiation from bone marrow cells.
To obtain DCs, we used a modified version of an already described method (26) . Bone marrow cells were cultured in bacterial petri dishes (100-mm diameter; Falcon) in RPMI 1640 supplemented with gentamicin (40 g/ml; Gibco BRL), 10% fetal calf serum (Gibco BRL), ␤-mercaptoethanol (50 M; Sigma), and granulocyte-macrophage colony-stimulating factor (20 ng/ml; Peprotech) for 9 days. The medium was changed on days 3 and 8. On day 6, half of the supernatant containing nonadherent cells was removed and centrifuged. The pellet was then resuspended in 10 ml culture medium and put back in a new petri dish. After 9 days, 70% of bone marrow-cultured cells expressed CD11c, as DCs do.
DC stimulation. DCs (0.5 ϫ 10 6 cells per culture well) were cultured for 24 h with anti-CD40 antibody (10 g/ml; Pharmingen), LPS (1 g/ml; Sigma), or B. burgdorferi (2.5 and 1 g/ml). Cells were then removed, centrifuged, and stained for flow cytometry analysis.
B-cell stimulation with IL-4. Purified B cells (anti-CD43 negative sorting; 0.5 ϫ 10 6 B cells per well) were cultured for 60 h at 37°C in the presence of murine IL-4 (0.1 ng/ml; Roche Diagnostics), with or without sonicated B. burgdorferi (10 g/ml). Unstimulated cells were used as controls.
RESULTS

B. burgdorferi infection in MyD88 KO mice. B. burgdorferi
induces a chronic infection in many inbred mouse strains, including C57BL/6. This infection is characterized by chronic bacteremia invading many tissues. The highest concentrations of spirochetes are found in the ankle joints, heart, and skin. Inflammation peaks about 2 to 4 weeks after infection and then regresses in the presence of B. burgdorferi-specific adaptive immune responses (6) . Since B. burgdorferi lipoproteins activate innate immune cells via TLRs, two recent studies have checked the importance of the adaptor molecule MyD88 in B. burgdorferi-induced inflammation and infection resolution. MyD88-deficient mice developed carditis and arthritis like wild-type (WT) mice did, but with higher pathogen burdens (7, 24) .
In the following experiments, 4-to 5-week-old MyD88 KO mice on the C57BL/6 background and MyD88 ϩ/Ϫ littermates were injected with B. burgdorferi or culture medium (BSK-H) and analyzed mostly 3 to 4 weeks after infection. Two weeks after B. burgdorferi infection, MyD88 KO mice developed severe arthritis as frequently as MyD88 ϩ/Ϫ mice did, indicating that MyD88-dependent signaling is not required for the onset of B. burgdorferi-induced disease. All infected mice had positive cultures from at least one tissue sample (heart, ear, or bladder) at 4 weeks. All KO mice mounted an anti-B. burgdorferi IgG response as well as MyD88 ϩ/Ϫ animals did (Table 1) , as already described (7, 24) . Surprisingly, B. burgdorferi infection induces considerable B-cell activation. B. burgdorferi spirochetes and their lipoproteins have been shown in vitro to possess mitogenic activity on WT mouse B lymphocytes (27, 48) . In vivo, B. burgdorferi induces polyclonal hypergammaglobulinemia in which B. burgdorferi-specific Ig represents only a minor fraction (7, 42) . Previous work suggests that TLRs present on the B-cell surface, particularly TLR2 and TLR1, could be involved (3, 13, 47) . Since most known mammalian TLRs, including TLR1/2 complexes, signal through the adaptor protein MyD88, one could expect that nonspecific B-cell activation would be abolished or seriously impaired in B. burgdorferi-infected MyD88 KO mice. Spleen and LN B cells from infected and noninfected MyD88 KO and MyD88 ϩ/Ϫ mice were analyzed by flow cytometry. Infection resulted in at least a threefold increase in LN B-cell numbers in MyD88 ϩ/Ϫ mice compared to those in control mice injected with culture medium alone. However, LN B-cell numbers of infected MyD88 KO mice reached at least 10 times the number of B cells in the noninfected animals ( Fig. 1A and B and Table 2 ). This increase concerned mostly IgM ϩ IgD ϩ mature B cells (Table 2) , as confirmed by the IgM/IgD/CD21/CD23 staining profile (not shown), with an abnormal activation state (CD86 staining intensity) ( Fig. 1C ). LN follicular organization (follicles, mantle zones, and germinal centers) appeared normal (not shown). In contrast, we found no significant modification in the splenic B-cell populations in both MyD88 KO and MyD88 ϩ/Ϫ mice, possibly reflecting the fact that the spleen only sporadically retains spirochetes (our culture results [not shown] and the PCR results of Wooten et al. [47] ).
We detected a strong IgM hypergammaglobulinemia in MyD88 KO animals. Consistent with previous work, B. burgdorferi infection resulted in a two-to fourfold increase in the serum concentration of total IgM in infected MyD88 ϩ/Ϫ animals compared with uninfected MyD88 ϩ/Ϫ controls. In MyD88 KO mice, this increase was dramatic, reaching 20 times the IgM levels of uninfected MyD88 KO mice ( Fig. 1D) (Fig. 1E) , even if the relative contributions of the IgG subclasses were modified, suggesting that both T-cell-dependent (IgG1 and IgE) and, to a higher degree, T-cell-independent (IgG3) responses were activated in the absence of MyD88 during B. burgdorferi infection ( Fig. 2A  and B ). Accordingly, both IgG1 and IgG3 anti-B. burgdorferi responses were enhanced in infected MyD88 KO mice (Fig. 2C) .
Recent evidence has demonstrated that MyD88 plays a significant role in the host defense against B. burgdorferi, with MyD88-deficient mice harboring larger numbers of spirochetes in the ankle joints, heart, and ears 2, 4, and 8 weeks after infection than do WT animals (7, 24) . Thus, we wondered whether our results could be the consequence of a higher bacterial burden in infected MyD88 KO mice than in infected MyD88 ϩ/Ϫ mice. We first used real-time PCR to quantify the B. burgdorferi flagellin DNA (fla) in joints and LN of the infected mice. After 20 days of infection, the mean number of flagellin copies was indeed 100 times higher in MyD88 KO mouse joints than in MyD88 ϩ/Ϫ mouse joints, but the amounts of B. burgdorferi organisms in MyD88 KO and MyD88 ϩ/Ϫ infected LN were moderate and similar (not shown). One could argue that B cells circulate and could encounter antigens and/or be sensitive to growth factors that are due to the high level of bacteria. However, B. burgdorferi-infected TLR2-deficient mice have also been shown to harbor up to 20-fold more spirochetes in tissues than do TLR2 ϩ/Ϫ littermates (7, 47; our unpublished results), and IgM production in infected TLR2 KO animals was comparable to that seen in infected MyD88 ϩ/Ϫ (WT) mice ( Fig. 1D ). Finally, we injected increasing amounts of B. burgdorferi (10 3 to 10 7 spirochetes) into C57BL/6, TLR2 KO, and MyD88 KO mice in order to get various bacterial levels by the end of the 20-day experiment. There was no strict correlation between IgM production and the B. burgdorferi bacterial burden (Fig. 3 ), but we could not rule out that the high pathogen burden in infected MyD88 KO mice contributed to B-cell hyperactivation.
B. burgdorferi-induced B-cell activation in MyD88 KO mice includes autoreactive B cells. Clinical observations and different experimental models show that autoreactive B cells can be activated during microbial infections. B. burgdorferi-infected
MyD88 KO mice produced high levels of several IgM autoantibodies, such as RF, anti-dsDNA, and anti-thyroglobulin antibodies, with levels similar to those found in the lupus-prone autoimmune strain MRL/lpr (Fig. 4) . In contrast, no IgG autoantibodies could be detected in their sera. MyD88 KO mice appeared healthy 4 weeks after infection, except for the induced arthritis. Likewise, 3 months after B. burgdorferi infection, MyD88 KO mice still showed B-cell activation, IgM hypergammaglobulinemia, and autoantibody production, with no sign of autoimmune disease, in particular no proteinuria (not shown). Together, these data suggest that these autoantibodies are natural autoantibodies.
In summary, although previous work strongly suggested the ability of B. burgdorferi to directly stimulate B cells via their TLRs, our results clearly indicate that the deficiency of the main adaptor of TLR signaling leads to B-cell expansion, IgM overproduction, and essentially no class switching after B. burgdorferi infection. In order to explain this phenotype, we ex- In order to elucidate this apparent paradox, we tested B-cell activation in vivo by cellular transfer. Purified B cells from MyD88 KO or MyD88 ϩ/Ϫ animals were transferred into MT mice, which lack mature B cells and are on a C57BL/6 background. Figure 5D summarizes the results of the transfer ex- periments. After B. burgdorferi infection, MyD88 ϩ/Ϫ B cells and MyD88 KO B cells were similarly represented in this C57BL/6 non-MyD88-deficient environment. More importantly, we did not observe any increase in IgM production in animals receiving MyD88 KO B cells compared to that in animals receiving MyD88 ϩ/Ϫ B cells. On the contrary, MyD88 KO B cells were even less able to produce IgM than were MyD88 ϩ/Ϫ B cells, suggesting that these cells are less responsive to B. burgdorferi when MyD88 is missing. Taken together, in vitro and in vivo results show that a MyD88-deficient non-B-cell partner is necessary to drive B-cell hyperactivation in response to B. burgdorferi infection. Table 2 and Fig. 6A, B. burgdorferi infection induces a significant increase of LN CD4 and CD8 T cells, although it is much less important than the B-cell increase, in MyD88 KO mice compared to MyD88 ϩ/Ϫ mice. To study the role of CD4 T lymphocytes, we treated MyD88 KO mice with a nondepleting anti-CD4 monoclonal antibody under conditions known to completely block CD4 ϩ cells for 4 weeks (8, 21, 42, 46) . As indicated in Fig. 6B , this treatment slightly reduced the number of LN B cells in infected MyD88 KO mice, although not significantly. However, the IgM levels were drastically reduced in anti-CD4-treated MyD88-deficient mice (Fig. 6C ). Thus, CD4 T cells strongly influence the hyper-IgM production in MyD88 KO mice infected with B. burgdorferi.
MyD88 KO T cells. Do MyD88-deficient T cells drive B-cell hyperactivation? As shown in
We next wondered if the absence of MyD88 in T cells was responsible for the observed B-cell phenotype for infected MyD88 KO mice. Purified T cells from MyD88 KO or MyD88 ϩ/Ϫ mice were transferred into T-cell-deficient animals (CD3ε-deficient mice) on a C57BL/6 background. Figure 6D summarizes the results of these transfer experiments. The absence or presence of MyD88 in T cells did not influence the a Results are expressed as means Ϯ standard deviations for groups of five to eight mice. Cellular phenotypes were assessed as described in the legends to Fig.  1 and 6. total number of B cells or the IgM level in infected recipients. We concluded from these experiments that the hyper-IgM observed in infected MyD88 KO mice is CD4 T cell dependent but independent of MyD88 signaling in T cells.
Recently, numbers of reports have suggested that CD4 ϩ regulatory T cells could be involved in suppressing B-cell functions (17, 37) . However, our data do not support a role for defective MyD88 KO regulatory T cells in the activated B-cell phenotype. Numbers of regulatory T cells, assessed by CD4 ϩ CD25 hi CD45RB low staining, were similar in MyD88 KO and MyD88 ϩ/Ϫ LN and increased in similar proportions with B. burgdorferi infection ( Fig. 6E and data not shown) . In addition, transfer systems of MyD88 KO or MyD88 ϩ/Ϫ T cells included similar numbers of regulatory T cells, with no influence on B-cell activation.
MyD88 KO DCs. TLR signaling activates DCs to secrete proinflammatory cytokines and upregulate costimulatory molecule expression, thereby linking innate and adaptive immunity (5, 9, 19) . It has also been suggested that during infections, DCs could negatively regulate the Th2 response in a MyD88dependent manner (44) .
Sera from infected and noninfected mice were analyzed for IL-4 (Th2 response), IL-12, and IFN-␥ levels (Th1 response). IL-4 was not detectable. The results for IL-12 and IFN-␥ are shown in Fig. 7A . Noninfected MyD88 KO animals displayed significantly less IL-12 and IFN-␥, and in contrast to the case for MyD88 ϩ/Ϫ mice, B. burgdorferi infection did not increase the production of these cytokines. These results suggest that MyD88 KO mice are defective in Th1 cell differentiation and that this defect is amplified during B. burgdorferi infection.
The Th2 differentiation of T cells leads to IL-4 production. In our model, we tested the responses of MyD88 ϩ/Ϫ and MyD88 KO non-B cells to B. burgdorferi. LN from infected MyD88 KO animals were B cell depleted. The non-B cells, including T cells and antigen-presenting cells representing the B-cell environment, were secondarily stimulated in vitro with B. burgdorferi. As shown in Fig. 7B , and confirming previous data (24), supernatants contained IL-4 but no IFN-␥ and no IL-12, which was not the case for supernatants originating from cultures of MyD88 ϩ/Ϫ non-B cells under the same conditions (Fig. 7C ). Finally, we verified that IL-4 was indeed able to stimulate MyD88 KO B cells in vitro (Fig. 7D) .
DC numbers in LN, based on CD11c expression, were similar in infected MyD88 ϩ/Ϫ and MyD88 KO mice (not shown). B. burgdorferi infection was associated with an increase in CD86 activation marker expression on DC surfaces in both MyD88 ϩ/Ϫ and MyD88 KO mice (Fig. 7E) . To further characterize the MyD88 KO DC response to B. burgdorferi, we generated mature DCs from bone marrow cultures with granulocyte-macrophage colony-stimulating factor and analyzed the activation status of DCs in terms of the expression of the activation marker CD86 and IL-12 production with direct B. burgdorferi stimulation. As a positive control, compared to MyD88 ϩ/Ϫ DCs, MyD88 KO DCs upregulated CD86 in response to CD40 cross-linking but displayed an altered response to LPS, as already described. The direct stimulation of MyD88 KO DCs with B. burgdorferi did not upregulate CD86 (Fig. 7F ) or induce IL-12 production ( Fig. 7G) , in contrast to the case for MyD88 ϩ/Ϫ DCs. These results show that although DCs from infected MyD88 KO mice upregulate CD86 in vivo, they are not directly activated by B. burgdorferi. Thus, we can speculate that a DC defect in MyD88 KO mice might contribute to the Th1-Th2 imbalance.
DISCUSSION
We have examined the polyclonal B-cell activation induced by B. burgdorferi infection in MyD88-deficient mice and have made the important observation that it is dramatically increased compared to what is observed in heterozygous control animals. We checked the level of the defect and found that it is not intrinsic to B cells, since (i) MyD88 deficiency rendered B cells unresponsive in vitro to B. burgdorferi and (ii) MyD88 KO and MyD88 ϩ/Ϫ B cells behaved similarly in a reconstituted WT environment. We also show that while CD4 cell function is required to drive polyclonal IgM overproduction, the MyD88 status of the T cells is not relevant. Finally, our experiments suggest that MyD88 KO DCs could be the source of the expansion of B cells in infected MyD88 KO mice.
It has already been suggested that Th1 effector responses require TLR-mediated recognition and signaling, whereas Th2 responses are independent of the TLR pathway (34, 40) . Our results agree with this view and with data showing impaired IL-12 and IFN-␥ production in MyD88 KO mice during various experimental infections (11, 31, 39) . At least two factors could be implicated in the activation of CD4 Th2 cells in B. burgdorferi-infected MyD88 KO mice, including the lack of IL-12 secretion and the production of IL-4 (30, 32). Indeed, it was proposed that in the absence of IL-12, Th2 differentiation becomes a default pathway by derepression of GATA3, a key transcription factor for Th2 differentiation. In fact, DCs from MyD88 KO mice have lost the ability to produce proinflammatory cytokines such as IL-12 in response to a large number of pathogen-associated molecular patterns (39, 40) , and in vitro studies have suggested that MyD88 in DCs could be critical for Th cell differentiation (18, 40) . On the other hand, IL-4, which is produced in minute amounts by naïve T cells and activates T cells along an autocrine loop, also promotes GATA3 expression. Other possibilities must be considered, among them the direct B. burgdorferi-induced activation of the Notch pathway leading to Th2 differentiation (4), T-bet deregulation (25) , and the direct activation by B. burgdorferi of other MyD88-deficient nonlymphoid cells able to produce cytokines. 
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MyD88 CONTROLS HYPERGAMMAGLOBULINEMIA 1663 on January 16, 2020 by guest http://iai.asm.org/ MyD88, originally described as a myeloid differentiation primary response protein, is an adaptor molecule in IL-1 receptor (IL-1R)/TLR signaling by interacting with the Toll/IL-1R domain (15) . Thereafter, IL-1R-associated kinases (IRAK-1, IRAK-2, IRAK-M, and IRAK-4) are recruited and, in turn, recruit TNFR-associated factor 6 (TRAF-6), leading to the activation of NF-B and AP-mediated genes. In addition to its role in the TLR activation pathway, MyD88 is an adaptor molecule for the IL-1 and IL-18 receptor signaling pathways (1) . Responses of IL-1R-deficient mice to several antigenic stimuli have already been described: IL-1R KO mice develop a Th2-like response following infection with the Th1-inducing pathogen Leishmania major as well as after immunization with keyhole limpet hemocyanin, although the mechanisms of this Th2 shift are not clearly understood (38) . IL-18 also stimulates Th1 differentiation, promoting IFN-␥ and IL-12 production and NK cell activation, and this Th1 cell development is altered in IL-18R-deficient mice (29) . However, the lack of B. burgdorferi-induced hyper-IgM in ICE-deficient mice (A. Woods, unpublished results) suggests that this phenomenon hinges on a TLR pathway deficiency. Several MyD88-dependent TLRs are involved in the B-cell response to B. burgdorferi (2, 3, 13, 47) , including TLR2 via the recognition of lipoproteins and TLR5 and TLR9 via the bacterial flagellin and DNA, explaining how MyD88 deficiency abolishes direct activation of B cells and DCs in response to B. burgdorferi. Indeed, the lack of hyper-IgM in B. burgdorferi-infected TLR2 KO mice could be the consequence of the binding of B. burgdorferi antigens to multiple TLRs. Thus, our results could reflect either (i) the blockade of the MyD88-dependent TLR cascade or (ii) the alteration of another unknown MyD88-dependent pathway (43) . This issue will require further work.
Regarding the consequences of such high levels of polyclonal hypergammaglobulinemia in infected MyD88 KO mice, one could be worried about the possible occurrence of autoimmunity. These mice have increased levels of different autoantibodies, including anti-DNA and RFs of the IgM class, compared to control WT mice. The lack of autoantibody class switching, combined with a possible lack of affinity maturation, could explain the absence of overt autoimmunity in these animals, at least within the time frame of our observation. In fact, compared to the IgM levels, the slightly increased level of total IgG in MyD88 KO B. burgdorferi-infected mice, as previously described (7), is similar to the IgG levels of infected MyD88 ϩ/Ϫ mice. What could be the interpretation of extremely high levels of IgM with only slightly elevated IgG levels? IgM overproduction in infected MyD88 KO mice is dependent on CD4 T cells and likely on IL-4 production. Thus, the partial class switch defect is probably linked to CD4 T-cell IL-4 production without cognate T-cell-B-cell cooperation (which should have induced a more pronounced Ig switch), circumventing the CD40 ligand role. Also, these results may reflect a defect in the Ig class switch recombination (CSR) process in MyD88 KO mice. Recently, in a mouse model of vaccination against human papillomavirus type 16, MyD88 KO mice developed only IgM. In this model, human papillomavirus type 16 caused naïve purified B cells to undergo CSR and to express ␥1, ␥2, and ␥3 H chain transcripts in WT animals, but only the transcript was detected in MyD88 KO mice (49) . However, MyD88 KO B cells still produced IgG in response to CD40 ligation and IL-4, demonstrating that they are able to undergo CSR. Thus, in B. burgdorferi-infected mice, CSR is partially allowed and, owing to the Th2 profile, accounts for the slightly increased IgG1 production in MyD88 KO mice.
Our data contrast with those published recently by Pasare and Medzhitov (34) and with their conclusion that in addition to CD4 ϩ T-cell help, the generation of T-cell-dependent antigen-specific antibody responses requires activation of TLRs in B cells. Neither T-cell-dependent polyclonal nor specific antibody production is prevented by MyD88 deficiency in B. burgdorferi infection. However, Pasare and Medzhitov mostly considered the anti-human serum albumin response in MyD88deficient B cells. Some differences in the results could be explained by the antigen and the condition of antigenic stimulation used (in our model, in vivo chronic bacterial infection).
In the end, we are left with a contrasting picture of MyD88's roles in this infectious model: on the one hand, it controls the potentially harmful hypergammaglobulinemia and autoantibody production, and on the other hand, it authorizes the production of hazardous class-switched autoantibodies. These results also alert us to the relevance of therapeutic selective inhibition targeting TLR signaling. Although TLRs have clearly been implicated in the genesis of autoimmune processes, the effect of the disruption of MyD88 interactions should be considered with caution (12) .
